The micron stroke hypothesis of Alzheimer's disease and dementia

Allen J Orehek1

  • 1Dementia Prevention Center™, 2637 E Atlantic Blvd #19129, Pompano Beach, FL 33062, USA. reprint@micronstroke.com

Medical Hypotheses
|March 3, 2012
PubMed

Insights

Alzheimer's disease and dementia may stem from numerous interacting causes, not a single origin. This hypothesis introduces "Micron Strokes" as a key factor in dementia development.

Area of Science:

  • Neurology
  • Gerontology
  • Pathogenesis research

Background:

  • Alzheimer's disease (AD) and dementia are often described symptomatically, lacking a definitive etiological theory despite extensive research.
  • Current understanding of AD pathogenesis is complex and fragmented, hindering effective treatment and prevention strategies.

Purpose of the Study:

  • To propose a new conceptual framework for understanding the etiology of Alzheimer's disease and dementia.
  • To introduce the concept of "Micron Strokes" as a unifying hypothesis for the multifactorial causes of dementia.

Main Methods:

  • Literature review and synthesis of existing hypotheses and research on Alzheimer's disease and dementia.
  • Development of a novel hypothesis, the "Micron Stroke Hypothesis," integrating primary and secondary etiological factors.

Main Results:

  • The hypothesis posits that dementia arises from numerous interacting causes rather than a single etiology.
  • Identifies primary factors including baseline brain tissue, atrial fibrillation, hypercoagulable state, LDL, carotid artery stenosis, tobacco exposure, hypertension, diabetes mellitus, and systemic inflammation.
  • Suggests that the interaction of these primary factors leads to "micron strokes" in the brain, contributing to dementia.

Conclusions:

  • Alzheimer's disease and dementia are likely multifactorial, challenging the search for a single cause.
  • The "Micron Stroke Hypothesis" offers a new perspective, integrating various risk factors into a cohesive model.
  • Further research is needed to validate the role of micron strokes in the pathogenesis of dementia.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...